OARSAi001-A

Registration Summary:

A P E C

S04

The cell line is not submitted yet.

(only basic data is shown)

General

Cell Line
hPSCreg name	OARSAi001-A
Cite as:	OARSAi001-A (RRID:CVCL_VN66)
Alternative name(s)	S04
Cell line type	Human induced pluripotent stem cell (hiPSC)
Similar lines	No similar lines found.
Last update	14th April 2022
User feedback	Written by on No feedback available yet. Login to share your feedback, experiences or results with the research community.
Provider
Generator	Office of Applied Research and Safety Assessment, CFSAN, U.S. FDA (OARSA) Contact: Office of Applied Research and Safety Assessment, CFSAN, U.S. FDA (OARSA)
Owner	Office of Applied Research and Safety Assessment, CFSAN, U.S. FDA (OARSA)
Distributors	Office of Applied Research and Safety Assessment, CFSAN, U.S. FDA (OARSA)
External Databases
BioSamples	SAMEA4760915
Cellosaurus	CVCL_VN66
Wikidata	Q98128266
General Information
Publications	Gao X et al. Generation of nine induced pluripotent stem cell lines as an ethnic diversity panel. Stem cell research. 2018 Aug;31:193-196. Gao X et al. Hepatocytes derived from human induced pluripotent stem cells: Towards establishing an in vitro model for assessing population variability in hepatotoxicity testing. Current research in toxicology. 2025;8:100238.
* Is the cell line readily obtainable for third parties?	Yes Research use: allowed Clinical use: not allowed Commercial use: not allowed

hIPSC Derivation

General